Volume 16, Issue 6, Pages (June 2019)

Slides:

Advertisements

Similar presentations

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Advertisements

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Volume 6, Issue 8, Pages e1 (August 2009)

Volume 5, Issue 8, Pages (August 2008)

Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness.

Copyright © 2006 American Medical Association. All rights reserved.

Volume 14, Issue 10, Pages (October 2017)

Volume 11, Issue 8, Pages (August 2014)

Volume 13, Issue 1, Pages (January 2016)

Erratum Heart Rhythm Volume 8, Issue 4, (April 2011)

Volume 5, Issue 4, Pages (April 2008)

Volume 8, Issue 5, Pages (May 2011)

Volume 14, Issue 9, Pages (September 2017)

Volume 9, Issue 1, Pages (January 2012)

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 14, Issue 5, Pages (May 2017)

Volume 9, Issue 4, Pages (April 2012)

Volume 6, Issue 12, Pages (December 2009)

Improved Mitral Valve Performance After Transapical Aortic Valve Implantation Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger,

Volume 11, Issue 1, Pages (January 2014)

Andre J. Gauri, MD, Andrew Davis, MD, Thomas Hong, MD, Martin C

Volume 13, Issue 7, Pages (July 2016)

Volume 15, Issue 9, Pages (September 2018)

Zachary R. McCaw, AM, Ariela R

Volume 7, Issue 4, Pages (April 2010)

Volume 14, Issue 12, Pages (December 2017)

Volume 11, Issue 2, Pages (February 2014)

Volume 9, Issue 1, Pages (January 2012)

Volume 11, Issue 2, Pages (February 2014)

Volume 8, Issue 12, Pages (December 2011)

Volume 5, Issue 8, Pages (August 2008)

Ethnic and racial disparities in cardiac resynchronization therapy

Volume 14, Issue 12, Pages (December 2017)

Mintu P. Turakhia et al. JACEP 2016;2:

Volume 15, Issue 1, Pages (January 2018)

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Volume 7, Issue 11, (November 2010)

Competing risks need to be considered in survival analysis models for cardiovascular outcomes Marianne Huebner, PhD, Martin Wolkewitz, Dr Sc Hum, Maurice.

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient Isla McClelland, MD,

Volume 5, Issue 7, Pages (July 2008)

Constance E. Ruhl, James E. Everhart Gastroenterology

Volume 9, Issue 1, Pages (January 2012)

Atrial fibrillation and the risk of incident dementia: A meta-analysis

Volume 7, Issue 7, Pages (July 2010)

Volume 14, Issue 3, Pages (March 2017)

Volume 16, Issue 1, Pages 3-9 (January 2019)

Volume 9, Issue 8, Pages S14-S17 (August 2012)

Volume 7, Issue 3, Pages (March 2010)

Michael R. Gold, MD, PhD, FHRS Heart Rhythm

Volume 15, Issue 1, Pages (January 2018)

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic.

Volume 11, Issue 3, Pages (March 2014)

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

HRS collaborates with leading medical societies to launch a voluntary laboratory accreditation program and drive quality improvement John D. Day, MD,

Volume 8, Issue 3, Pages (March 2011)

Volume 10, Issue 9, Pages (September 2013)

Impact of generator replacement on the risk of Fidelis lead fracture

Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination–Implantable.

Prosthesis–patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: Effect on survival,

Mitral Repair Versus Replacement for Ischemic Mitral Regurgitation

Volume 16, Issue 7, Pages (July 2019)

Francisco Alcocer, MD, Marjan Mujib, MD, Bruce Lowman, MD, Mark A

Sex Differences in the Management and 5-Year Outcome of Young Patients (

(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm? Andrew W. ElBardissi, MD, MPH, Daniel.

Presentation transcript:

Volume 16, Issue 6, Pages 813-819 (June 2019) Arrhythmic burden among asymptomatic patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator Avi Sabbag, MD, Michael Glikson, MD, FHRS, Mahmoud Suleiman, MD, Monther Boulos, MD, Ilan Goldenberg, MD, PhD, Roy Beinart, MD, Eyal Nof, MD Heart Rhythm Volume 16, Issue 6, Pages 813-819 (June 2019) DOI: 10.1016/j.hrthm.2019.03.030 Copyright © 2019 Terms and Conditions

Figure 1 Kaplan-Meier analysis of cumulative survival by New York Heart Association (NYHA) functional class. Heart Rhythm 2019 16, 813-819DOI: (10.1016/j.hrthm.2019.03.030) Copyright © 2019 Terms and Conditions

Figure 2 Fine and Gray analysis of cumulative survival free of appropriate defibrillator therapy adjusted for death as a competing risk. NYHA = New York Heart Association. Heart Rhythm 2019 16, 813-819DOI: (10.1016/j.hrthm.2019.03.030) Copyright © 2019 Terms and Conditions

Figure 3 Hazard ratio (HR) for appropriate therapy with 95% confidence interval (CI) controlled for death as a competing risk. NYHA = New York Heart Association. Heart Rhythm 2019 16, 813-819DOI: (10.1016/j.hrthm.2019.03.030) Copyright © 2019 Terms and Conditions

Supplemental Figure 1A Cumulative incidence of mortality and appropriate defibrillator therapy in A) in patients without heart failure symptoms. Heart Rhythm 2019 16, 813-819DOI: (10.1016/j.hrthm.2019.03.030) Copyright © 2019 Terms and Conditions

Supplemental Figure 1B Cumulative incidence of mortality and appropriate defibrillator therapy in patients with heart failure symptoms. Heart Rhythm 2019 16, 813-819DOI: (10.1016/j.hrthm.2019.03.030) Copyright © 2019 Terms and Conditions